首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment
【24h】

Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment

机译:对人诱导多能干细胞衍生心肌细胞培养性的培养基对比较分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Introduction: Cardiotoxicity assessment using human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) forms a key component of the Comprehensive in Vitro Proarrhythmia Assay (CiPA). A potentially impactful factor on iPSC-CM testing is the presence of serum in the experimental media. Generally, serum-free media is used to most accurately reproduce "free" drug concentration. However, caution is needed; drug solubility and cardiomyocyte electrophysiology could be affected by media formulation, potentially impacting interpretation of drug-induced effects.
机译:介绍:使用人诱导的多能干细胞衍生心肌细胞(IPSC-CMS)的心脏毒性评估形成综合体外预血管性测定(CIPA)的关键组分。 IPSC-CM测试的潜在影响因素是实验介质中存在血清。 通常,无血清介质用于最精确地再现“自由”的药物浓度。 但是,需要谨慎; 药物溶解度和心肌细胞电生理学可能受培养基配方的影响,可能影响药物诱导的效果的解释。

著录项

  • 来源
  • 作者单位

    US FDA Ctr Devices &

    Radiol Hlth Off Sci &

    Engn Labs Div Biomed Phys 10903 New Hampshire Ave;

    US FDA Ctr Devices &

    Radiol Hlth Off Sci &

    Engn Labs Div Biomed Phys 10903 New Hampshire Ave;

    US FDA Ctr Drug Evaluat &

    Res Off New Drugs Div Cardiovasc &

    Renal Prod 10903 New Hampshire Ave;

    US FDA Ctr Devices &

    Radiol Hlth Off Sci &

    Engn Labs Div Biomed Phys 10903 New Hampshire Ave;

    US FDA Ctr Devices &

    Radiol Hlth Off Sci &

    Engn Labs Div Biomed Phys 10903 New Hampshire Ave;

    US FDA Ctr Drug Evaluat &

    Res Off Clin Pharmacol Div Appl Regulatory Sci 10903 New Hampshire;

    US FDA Ctr Drug Evaluat &

    Res Off Clin Pharmacol Div Appl Regulatory Sci 10903 New Hampshire;

    Axion BioSyst Inc 1819 Peachtree Rd NE Suite 350 Atlanta GA 30309 USA;

    Axion BioSyst Inc 1819 Peachtree Rd NE Suite 350 Atlanta GA 30309 USA;

    Axion BioSyst Inc 1819 Peachtree Rd NE Suite 350 Atlanta GA 30309 USA;

    US FDA Ctr Drug Evaluat &

    Res Off Clin Pharmacol Div Appl Regulatory Sci 10903 New Hampshire;

    US FDA Ctr Devices &

    Radiol Hlth Off Sci &

    Engn Labs Div Biomed Phys 10903 New Hampshire Ave;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号